IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.911
EU - Europa 22.496
AS - Asia 20.099
SA - Sud America 4.456
Continente sconosciuto - Info sul continente non disponibili 1.120
AF - Africa 390
OC - Oceania 31
Totale 71.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.352
RU - Federazione Russa 11.717
SG - Singapore 7.258
CN - Cina 6.013
IT - Italia 4.485
BR - Brasile 3.581
HK - Hong Kong 2.515
SE - Svezia 1.889
VN - Vietnam 1.691
FR - Francia 940
BD - Bangladesh 895
DE - Germania 856
CA - Canada 743
GB - Regno Unito 628
IN - India 466
FI - Finlandia 380
RO - Romania 311
AR - Argentina 302
MX - Messico 258
NL - Olanda 207
AT - Austria 191
IE - Irlanda 187
PL - Polonia 176
ES - Italia 164
JP - Giappone 164
ID - Indonesia 159
ZA - Sudafrica 149
EC - Ecuador 147
TR - Turchia 137
IQ - Iraq 132
CO - Colombia 130
CR - Costa Rica 121
JM - Giamaica 95
UA - Ucraina 81
VE - Venezuela 75
PK - Pakistan 74
MY - Malesia 60
PY - Paraguay 59
NP - Nepal 58
PH - Filippine 57
CL - Cile 55
HN - Honduras 54
SA - Arabia Saudita 53
LT - Lituania 51
MA - Marocco 50
UZ - Uzbekistan 48
GT - Guatemala 47
PE - Perù 45
NI - Nicaragua 44
SV - El Salvador 44
TN - Tunisia 42
AE - Emirati Arabi Uniti 41
UY - Uruguay 37
EG - Egitto 35
MD - Moldavia 34
IL - Israele 33
KE - Kenya 33
TT - Trinidad e Tobago 32
PR - Porto Rico 29
BE - Belgio 28
CH - Svizzera 27
PT - Portogallo 27
IR - Iran 26
DZ - Algeria 24
JO - Giordania 22
AU - Australia 21
CW - ???statistics.table.value.countryCode.CW??? 21
TW - Taiwan 19
EE - Estonia 17
GP - Guadalupe 17
KR - Corea 17
BH - Bahrain 16
BO - Bolivia 16
DO - Repubblica Dominicana 16
TH - Thailandia 16
OM - Oman 15
KZ - Kazakistan 14
LB - Libano 14
AZ - Azerbaigian 13
RS - Serbia 13
AL - Albania 12
GR - Grecia 12
BB - Barbados 11
PA - Panama 11
CY - Cipro 10
PS - Palestinian Territory 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
BG - Bulgaria 8
SN - Senegal 8
CI - Costa d'Avorio 7
GE - Georgia 7
GY - Guiana 7
KG - Kirghizistan 7
AO - Angola 6
BS - Bahamas 6
BY - Bielorussia 6
EU - Europa 6
KH - Cambogia 6
KW - Kuwait 6
Totale 70.273
Salva come PNG Salva come JPEG
Città #
Ashburn 3.355
Singapore 3.303
San Jose 2.553
Hong Kong 2.471
Moscow 2.461
Dallas 2.336
Milan 1.224
Council Bluffs 1.139
Shanghai 1.014
Hefei 881
New York 743
Beijing 732
Lauterbourg 730
Princeton 595
Lawrence 594
Ho Chi Minh City 584
Santa Clara 502
Los Angeles 500
Phoenix 377
Hanoi 373
São Paulo 352
Rome 326
Nuremberg 222
Boardman 211
Munich 199
Orem 195
Helsinki 191
Dublin 185
London 184
North Bergen 172
Miano 163
Atlanta 160
Montreal 159
Brooklyn 145
Warsaw 141
Chicago 140
Naples 135
Rio de Janeiro 130
Denver 127
Tokyo 124
Washington 121
Chennai 118
Toronto 111
Frankfurt am Main 96
The Dalles 96
Turku 96
Omaha 94
Pune 93
Buffalo 91
Poplar 91
Boston 88
Lappeenranta 87
Seattle 87
Stockholm 87
Vienna 87
Johannesburg 85
Bologna 84
Mexico City 84
San José 84
Guangzhou 82
Houston 81
Belo Horizonte 79
Columbus 75
Da Nang 74
San Francisco 70
Manchester 69
Kingston 64
Brasília 63
Haiphong 62
Turin 61
Cesano Boscone 58
Florence 58
Philadelphia 57
Baghdad 55
Amsterdam 54
Mumbai 54
Ankara 53
Shenzhen 52
Dhaka 51
Brescia 50
Tianjin 49
Quito 48
Miami 46
Charlotte 45
Biên Hòa 44
Curitiba 44
Palermo 44
Campinas 43
Managua 43
Guayaquil 42
Hangzhou 42
Las Vegas 42
Porto Alegre 41
Tashkent 41
San Salvador 40
Genoa 38
Guarulhos 38
The Bronx 37
New Delhi 36
Newark 35
Totale 34.068
Salva come PNG Salva come JPEG
Nome #
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes 427
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 375
Pancreatoblastoma in adults: a review of the literature. 255
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3 229
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis 224
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 212
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 212
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 208
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 208
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 208
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 206
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 204
European evidence-based guidelines on pancreatic cystic neoplasms 203
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 200
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 198
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma 197
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 197
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 189
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 188
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 178
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 178
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 176
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 172
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 172
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 166
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 163
Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol 162
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 160
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 160
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery 158
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 158
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 158
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 156
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 156
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 155
A delphic consensus assessment: Imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management 154
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 152
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 151
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 150
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 150
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 150
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 149
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 148
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 148
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 147
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 146
Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS) 145
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 145
A preoperative score to predict early death after pancreatic cancer resection 145
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 145
A multimodality test to guide the management of patients with a pancreatic cyst 143
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 142
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 142
The impact of preoperative anemia on pancreatic resection outcomes 141
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 141
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 140
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 140
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 140
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 139
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 138
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After 136
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 136
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 135
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 134
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 134
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 134
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 134
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 134
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 133
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 133
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 132
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 132
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 132
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 132
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 131
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 131
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 130
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 130
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 129
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 129
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 129
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 128
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 128
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 128
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 127
Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS) 127
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 126
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 126
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 126
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 126
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 126
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 126
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis 126
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 125
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 125
Urgent manifestations of immunoglobulin G4-related disease 125
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 124
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma 124
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. 124
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 124
Totale 15.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 408.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 408.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 0 123 31 15 16 9 21 17 9 43
2022/20233.706 1.329 743 218 48 39 397 325 325 167 32 34 49
2023/20242.648 70 132 296 250 249 555 74 268 43 105 189 417
2024/202512.216 1.365 326 326 364 425 1.064 1.795 1.006 2.053 1.594 893 1.005
2025/202640.625 2.730 3.035 2.755 5.243 2.859 1.233 3.613 2.890 10.705 2.365 1.565 1.632
2026/202711.787 1.701 2.839 2.418 4.829 0 0 0 0 0 0 0 0
Totale 71.503